REALM-DCM: a phase 3, multinational, randomized, placebo-controlled study of ARRY-371797 (PF-07265803) in patients with symptomatic LMNA-related dilated cardiomyopathy
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Coruna University Hospital Complex, Coruna, A (Spain)
5 More presentations in this session
Assistant Professor N. Bomer (Groningen, NL)
Doctor R. Rascon Sabido (Veracruz, MX)
Doctor M. Amiguet Comins (Castellon de la Plana, ES)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
